arrow
C

Claudia Voena

University of Turin
H指数:37
被引数:4,632

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Osmotic Remodeling of Extracellular Vesicles for Precision Nanomedicine (Small 56/2026)

外泌体渗透性重塑用于精准纳米医学 (Small 56/2026)

Small
IF12.1
2026-10-120
OAAI
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma (vol 25, pg 130, 2019)

Wiskott-Aldrich综合征蛋白(WASP)是T细胞淋巴瘤中的肿瘤抑制因子(卷25,页130,2019)

2026-03-010
PRE
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma

CD4+ T细胞调控ALK阳性T细胞淋巴瘤的免疫应答

Blood
IF23.1
2026-01-010
OA
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic Leukemia

评估AID诱导突变在慢性淋巴细胞白血病中对B细胞受体通路抑制剂耐药性的作用

2025-12-100
OA
Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell Neoplasms

人类和鼠类ALK阳性B细胞肿瘤的DNA甲基化比较分析

2025-07-260
OA
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency (vol 35, pg 3854, 2016)

NPM-ALK致癌信号过表达促进细胞凋亡和药物依赖(vol 35, pg 3854, 2016)

2025-05-020
PRE
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
2023-07-1021
PRE
Targeting CCR7-PI3K? overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
2023-06-286
PRE
DNA repair mechanisms that promote insertion-deletion events during immunoglobulin gene diversification
2023-03-317
OA
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
2022-12-013
OA
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
2021-12-086
OA
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients

LIGHT/TNFSF14促进非小细胞肺癌患者的溶骨性骨转移

2019-12-1131
OAAI
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
2018-12-0357
OAAI